Radiofrequency (RF) ablation was recently introduced as a novel ablation modality for hepatocellular carcinoma (HCC). Several investigators have reported that percutaneous RF ablation for patients with small HCC nodules provide favorable survival with excellent local control. However, several limitations of RFA have been pointed out, such as limited coagulated necrosis and relatively frequent local recurrences in large HCC. The critical factors for treatment success in large tumors included (a) the target diameter of an ablation-or of overlapping ablations -must be larger than the diameter of the tumor that undergoes treatment; (b) reduce the negative effect of blood flow and tissue perfusion on RF heating. To overcome RF limitations, researchers developed several techniques and skills of percutaneous treatments and several studies have demonstrated that multiple RF ablation processes with overlapping of ablation zones or combination therapies are feasible for large liver tumors. In this review, we analyzed varies of treatment strategies for percutaneous RF of large tumors and summarized the efficacy of clinical application.
Introduction
RF ablation was recently introduced as a novel ablation modality for HCC 1) 2) . For adequate destruction of tumor tissue, the entire target volume must be subjected to cytotoxic temperatures. Different physical mechanisms are involved in the hepatic hyperthermic treatments in order to generate a lethal temperature. A common important factor that affects the success of thermal ablation is the ability to ablate all viable tumor tissue and possibly an adequate tumor-free margin. Ideally, a 360°, 0.5-1-cm-thick ablative margin should be produced around the tumor. This cuff would ensure that microscopic invasions around the periphery of a tumor have been eradicated. Thus, the target diameter of an ablation-or of overlapping ablations -must be larger than the diameter of the tumor that undergoes treatment 
Overlapping model and method
Because most RF device produced limited ablation area and the complete ablation of a tumor requires safety margins, these performances are clearly insufficient for the proper treatment of a tumor target larger than 3 cm in a single application. Therefore, to ensure entire coverage of the targeted zone with monopolar devices, multiple overlapping RF ablations with successive positionings of the electrode are required. Dodd et al 7) reported their results of computer analysis of the thermal injury sizes created by overlapping ablations and proposed 6 and 14-ablation models. Their results demonstrated the importance of performing these types of calculations to develop tumor ablation strategies. Using a mathematical model to calculate the optimal number of RF ablation process for the target tumor, our group established a preoperative protocol for ultrasonographically guided percutaneous RF ablation of large liver tumors 8) .
A regular prism and a regular polyhedron model were used to develop a preoperative protocol for liver tumor ablation (Fig. 1) . This protocol en- . Before RF, we used color ultrasound to detect the tumor blood supply and identify the entrance of feeding vessel.
As the first step of the percutaneous RF treatment, 2-3 overlapping high energy ablating foci, 2-3 cm each in diameter, were used to ablate the entering site of the feeding vessel (Fig. 2) . Color Doppler ultrasound was used to confirm the absence of feeding artery. Blocking the blood flow in the tumor is helpful in decreasing heat loss during RF, and therefore the outcome improves. In our study, percutaneous RF to block feeding vessels were performed in >3 cm and hypervas- 19) .
Combining adjuvant cytotoxic therapies
Previously, local hyperthermia was used to increase . In a randomized pilot clinical study, Goldberg et al administered liposomal doxorubicin 24 hours before RF ablation in 10 patients with 18 intrahepatic lesions 23) . With this combination of RF ablation with adjuvant liposomal doxorubicin therapy, the authors were able to achieve increases of 25%-30% in coagulation volume in all tumors that received combination therapy compared with RF ablation alone. 
E f f i c a cy a n d c o m p l i c a t i o n s i n c l i n i c a l application
The problems with ablating a large tumor are not trivial. Livraghi et al 25) . In our recent report 28) , 172 patients who had 176 >3.5 cm HCC and were not candidate for surgery or TACE were enrolled in this study. Established strategy for 
